Are you a new member? Sign up now
Login area
| Sign up
close
SANDOSTATIN LAR - 20mg - 1
| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| H01CB02 | B | Octreotide (acetate) - 20mg | 5848 | 218903/10 | SANDOSTATIN LAR | 20mg | 1 | Injectable powder for suspension+diluent | IM | Khalil Fattal & Fils S.A.L. | Sandoz GmbH | Austria | 39,059,964 L.L | 10.71 | E1 | Novartis Pharma AG | Switzerland | 2/5/2024 | 0 |
Drugs With Same Ingredients
| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| H01CB02 | B | Octreotide (acetate) - 20mg | 5848/388 | 218903/10 | SANDOSTATIN LAR | 20mg | 1 | Injectable powder for suspension+diluent | IM | Khalil Fattal & Fils S.A.L. | Sandoz GmbH | Austria | L.L | 10.71 | E1 | Novartis Pharma AG | Switzerland | 2/5/2024 |
Sitemap
© Copyrights reserved to Ministry of Public Health 2024